Pioneering gene therapies for rare central nervous system (CNS) diseases
Please note that for mobiles we stream the presentation slides and audio of the speaker.
Ms Karen Aiach begins by explaining Lysogene's progress in using gene therapy to treat young children with rare CNS diseases, using her experience with her own child. Dr Michel Zerah continues, revealing Lysogene’s work, from direct-to-brain therapy to the optimisation of the surgical procedure.
This lecture was filmed at the Royal Society of Medicine's 14th Medical Innovations Summit on April 22nd 2017